Body
Data from the world's most comprehensive concussion study is now publicly available in a repository aimed at providing traumatic brain injury researchers access to a wealth of new knowledge.
The U.S. Department of Defense announced recently that data from the NCAA-DoD Concussion Assessment, Research and Education (CARE) Consortium is now available through the Federal Interagency Traumatic Brain Injury Research (FITBIR) informatics system.
TAMPA, Fla. (July 24, 2019)- We're in the midst of summertime mosquito bite season and cities across the country are reporting a heightened number of West Nile Virus (WNV) cases. The house sparrow is one of the most common carriers of WNV in urban areas. Mosquitos feed off the infected birds and spread the virus to humans. New research finds house sparrows exposed to artificial light at night, such as what's used in parking lots, maintain higher burdens of WNV for longer than those who spend their nights in the dark.
San Antonio, Texas (July 24, 2019) - A team of scientists led by Texas Biomed's Assistant Professor Smita Kulkarni, Ph.D. and Mary Carrington, Ph.D., at the Frederick National Laboratory for Cancer Research, published results of a study that pinpointed a long noncoding RNA molecule which influences a key receptor involved in HIV infection and progression of the disease. This newly-identified mechanism could open up a new avenue for control of HIV, the virus that causes AIDS.
The article was published in a recent edition of the journal Nature Immunology.
Although 27 percent of all older adults who live in nursing homes in this country have both high blood pressure and dementia, we don't have enough research yet to inform healthcare providers about the best way to treat their high blood pressure.
Use of medical imaging during pregnancy increased significantly in the United States, a new study has found, with nearly a four-fold rise over the last two decades in the number of women undergoing computed tomography (CT) scans, which expose mothers and fetuses to radiation. Pregnant women are warned to minimize radiation exposure.
The South African study shows that dolutegravir-containing regimens perform as well as the current efavirenz-containing one used for first-line antiretroviral treatment (ART) in South Africa and most of Africa.
These data are important in showing how dolutegravir and a new form of tenofovir (called tenofovir alafenamide - or TAF) perform in African populations, and in providing the scientific backing for the move to dolutegravir-containing regimens from efavirenz-containing ones worldwide.
First scientific study of compensatory strategies -- techniques to camouflage autism -- finds that they have positive and negative outcomes, increasing social integration, but possibly also resulting in poor mental health for autistic people, and could be a barrier to diagnosis.
In a study of open-label Truvada as daily pre-exposure prophylaxis (PrEP) to prevent HIV among 427 young African women and adolescent girls, 95% initiated the HIV prevention strategy, and most used PrEP for the first three months. However, PrEP use fell among participants in this critical population during a year of follow-up clinic visits, although HIV incidence at 12 months was low. The preliminary results suggest that tailored, evidence-based adherence support strategies may be needed to durably engage young African women in consistent PrEP use.
University of Guelph researchers are the first to uncover how the cannabis plant creates important pain-relieving molecules that are 30 times more powerful at reducing inflammation than Aspirin.
The discovery unlocks the potential to create a naturally derived pain treatment that would offer potent relief without the risk of addiction of other painkillers.
Certain therapies that have proven effective in treating some types of breast cancers are ineffective for women diagnosed with triple-negative breast cancer (TNBC). In fact, there is limited targeted drug therapy for this type of breast cancer -- the most aggressive type, diagnosed in about 20 percent of breast cancer patients.
But a new study by University of Notre Dame researcher Siyuan Zhang and collaborators, published in Nature Communications, shows that an existing, FDA-approved drug that treats other types of breast cancer may work for TNBC.
BOSTON - Knowledge of the biological processes involved in the development of the uterus is important for understanding uterine health and fertility. A research team led by investigators at Massachusetts General Hospital (MGH) has uncovered important insights on a type of cell that is critical for the formation of a functioning uterus.
BIRMINGHAM, Ala. - A de novo gene mutation that encodes a brain protein in a child with autism has been placed into the brains of mice. These mice then showed severe alterations of specific behaviors that closely resemble those seen in human autism spectrum disorder, or ASD.
A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.
Rheumatoid arthritis patients getting little or no relief from conventional small-molecule drugs and injectable biologic drugs saw substantial improvement in their condition from daily use of an experimental compound in a large 24-week study led by a Stanford University School of Medicine investigator.
A paper describing the results of the double-blind, randomized phase-3 clinical trial will be published July 23 in JAMA.
The large-scale analysis carried out by La Trobe University researchers and published in Heart found that many Australians living with CHD are under-prescribed recommended medications, are not monitored for major risk factors and have treatments that do not achieve recommended goals. In particular, women and those aged less than 45 years were more likely to be under-treated compared with similarly affected men and older people.